source
- Genetic markers linked to Yescarta toxicity identified, opening path to safer CAR-T designsResearchers analyzed data from patients who received Kite Pharma's Yescarta CAR-T therapy in clinical trials. The analysis uncovered specific genetic signatures that correlate with higher risk of…
- Merck grants royalty-free licenses for experimental HIV prevention pill to generic makers in 129 low-income countriesMerck announced voluntary licensing agreements that let generic manufacturers produce its experimental HIV prevention pill, known as alimatravir, in low- and middle-income markets. The deals cover…STAT · 3mo agoDealPositive